Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$751M |
| 2 |
Home Depot
HD
|
+$408M |
| 3 |
Altria Group
MO
|
+$378M |
| 4 |
SMBS
Schwab Mortgage-Backed Securities ETF
SMBS
|
+$298M |
| 5 |
Texas Instruments
TXN
|
+$260M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$868M |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$819M |
| 3 |
Amgen
AMGN
|
+$552M |
| 4 |
Merck
MRK
|
+$482M |
| 5 |
Cisco
CSCO
|
+$433M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.87% |
| 2 | Financials | 11.48% |
| 3 | Healthcare | 9.94% |
| 4 | Consumer Discretionary | 9.29% |
| 5 | Industrials | 8.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TVRD
3426
Tvardi Therapeutics
TVRD
$22.1M
| $50.7K | ﹤0.01% |
11,802
-3,472
| -23% | -$31.1K |
|
|
AGEN
3427
Agenus
AGEN
$307M
| $47.3K | ﹤0.01% |
15,061
-5
| -0% | -$20 |
|
3428
Atossa Therapeutics
ATOS
$23.6M
| $47.2K | ﹤0.01% |
5,333
| – | – |
|
3429
Genasys
GNSS
$76.1M
| $44.9K | ﹤0.01% |
20,918
| – | – |
|
|
MRDN
3430
Meridian Holdings Inc
MRDN
$177M
| $43.3K | ﹤0.01% |
4,504
| – | – |
|
3431
GrowGeneration
GRWG
$89.5M
| $42K | ﹤0.01% |
28,023
| – | – |
|
|
FLD
3432
Fold Holdings
FLD
$22.9M
| $41.2K | ﹤0.01% |
+15,777
| New | +$52.2K |
|
3433
Marchex
MCHX
$77.1M
| $40.4K | ﹤0.01% |
24,313
| – | – |
|
3434
Anixa Biosciences
ANIX
$110M
| $39.9K | ﹤0.01% |
12,785
| – | – |
|
3435
NeoVolta
NEOV
$178M
| $39.4K | ﹤0.01% |
12,964
| – | – |
|
3436
Zedge
ZDGE
$38.8M
| $37.1K | ﹤0.01% |
11,319
| – | – |
|
3437
Vivani Medical
VANI
$120M
| $36.9K | ﹤0.01% |
30,016
| – | – |
|
3438
NN Inc
NNBR
$301M
| $36.4K | ﹤0.01% |
28,401
| – | – |
|
3439
Aemetis
AMTX
$123M
| $36.3K | ﹤0.01% |
26,144
+84
| +0.3% | +$169 |
|
3440
Sera Prognostics
SERA
$77.9M
| $35.7K | ﹤0.01% |
12,085
-7
| -0.1% | -$23 |
|
3441
Tenaya Therapeutics
TNYA
$168M
| $35.6K | ﹤0.01% |
50,000
| – | – |
|
3442
Black Diamond Therapeutics
BDTX
$120M
| $35.2K | ﹤0.01% |
14,484
| – | – |
|
3443
RAVE Restaurant Group
RAVE
$44.1M
| $33K | ﹤0.01% |
10,012
| – | – |
|
3444
PetMed Express
PETS
$42.3M
| $32.2K | ﹤0.01% |
10,067
+67
| +0.7% | +$168 |
|
3445
Solitario Resources
XPL
$74.8M
| $31.3K | ﹤0.01% |
44,899
| – | – |
|
3446
Research Frontiers
REFR
$17.2M
| $28.6K | ﹤0.01% |
21,870
| – | – |
|
|
PMI
3447
Picard Medical
PMI
$7.46M
| $28.2K | ﹤0.01% |
+323
| New | +$76K |
|
3448
DHI Group
DHX
$166M
| $27.3K | ﹤0.01% |
17,605
| – | – |
|
3449
Tevogen Inc. Common Stock
TVGN
$28.1M
| $27.2K | ﹤0.01% |
1,642
+112
| +7% | +$2.91K |
|
|
SAFX
3450
XCF Global Inc
SAFX
$180M
| $24.5K | ﹤0.01% |
89,675
| – | – |
|
Similar funds
Charles Schwab's Q4 2025 Portfolio in Review
As of Q4 2025, Charles Schwab held 3,523 positions worth $644B, up 2.7% from $626B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Trading was light in Q4 2025: portfolio turnover was 3.8%. Charles Schwab opened 68 new positions and exited 67, leaving the 3,523-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 25% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q4 2025 buy was Qnity Electronics Inc: 1,489,517 shares worth $122M.
- Charles Schwab added most to Meta Platforms (Facebook) in Q4 2025, an estimated $751M increase.
- Charles Schwab's biggest Q4 2025 reduction was Broadcom, cutting an estimated $868M.
- Charles Schwab fully exited Vanguard S&P 500 ETF in Q4 2025, selling an estimated $819M.
- Charles Schwab's ten largest holdings make up 25% of its $644B portfolio in Q4 2025.
- Charles Schwab opened 68 new positions and closed 67 in Q4 2025.
- Charles Schwab's portfolio value rose 2.7% quarter-over-quarter to $644B.
Based on Charles Schwab's 13F filing for Q4 2025, filed 13 Feb 2026.